Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bert van Ramshorst

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
International Journal of Cancer|July 9, 2013
Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factorsIrene Thomassen, Yvette R van Gestel, Bert van Ramshorst, et al.
Clinical Pharmacokinetics|May 5, 2016
Does Weight Impact Anidulafungin Pharmacokinetics?Vincent J Lempers, Anne van Rongen, Eric P van Dongen, et al.
Obesity Surgery|February 4, 2012
Anti-Xa Levels 4 h After Subcutaneous Administration of 5,700 IU Nadroparin Strongly Correlate with Lean Body Weight in Morbidly Obese PatientsJeroen Diepstraten, Christian M Hackeng, Simone van Kralingen, et al.
Pancreas|April 21, 2007
Rupture of infected peripancreatic necrosis to the peritoneal cavity with fatal outcomeMarc G H Besselink, Thomas L Bollen, Robert C H Scheffer, et al.
Pharmaceutical Research|July 24, 2015
The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric SurgeryMargreke J Brill, Anne van Rongen, Eric P van Dongen, et al.
Journal of Surgical Oncology|April 26, 2016
Cytoreductive surgery and HIPEC offers similar outcomes in patients with rectal peritoneal metastases compared to colon cancer patients: a matched case control studyGeert A Simkens, Thijs R van Oudheusden, Hidde J Braam, et al.
Annals of Surgical Oncology|July 8, 2015
Treatment-Related Mortality After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis is Underestimated by Conventional ParametersGeert A Simkens, Thijs R van Oudheusden, Hidde J Braam, et al.
British Journal of Clinical Pharmacology|December 15, 2010
Comparative evaluation of atracurium dosed on ideal body weight vs. total body weight in morbidly obese patientsSimone van Kralingen, Ewoudt M W van de Garde, Catherijne A J Knibbe, et al.
Annals of Surgical Oncology|March 28, 2014
Cytoreduction and hyperthermic intraperitoneal chemotherapy: a feasible and effective option for colorectal cancer patients after emergency surgery in the presence of peritoneal carcinomatosisThijs R van Oudheusden, Hidde J Braam, Simon W Nienhuijs, et al.
Surgical Endoscopy|February 14, 2008
Timing of cholecystectomy after endoscopic sphincterotomy for common bile duct stonesAnandi H W Schiphorst, Marc G H Besselink, Djamila Boerma, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
International Journal of Cancer|July 9, 2013
Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factorsIrene Thomassen, Yvette R van Gestel, Bert van Ramshorst, et al.
Clinical Pharmacokinetics|May 5, 2016
Does Weight Impact Anidulafungin Pharmacokinetics?Vincent J Lempers, Anne van Rongen, Eric P van Dongen, et al.
Obesity Surgery|February 4, 2012
Anti-Xa Levels 4 h After Subcutaneous Administration of 5,700 IU Nadroparin Strongly Correlate with Lean Body Weight in Morbidly Obese PatientsJeroen Diepstraten, Christian M Hackeng, Simone van Kralingen, et al.
Pancreas|April 21, 2007
Rupture of infected peripancreatic necrosis to the peritoneal cavity with fatal outcomeMarc G H Besselink, Thomas L Bollen, Robert C H Scheffer, et al.
Pharmaceutical Research|July 24, 2015
The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric SurgeryMargreke J Brill, Anne van Rongen, Eric P van Dongen, et al.
Journal of Surgical Oncology|April 26, 2016
Cytoreductive surgery and HIPEC offers similar outcomes in patients with rectal peritoneal metastases compared to colon cancer patients: a matched case control studyGeert A Simkens, Thijs R van Oudheusden, Hidde J Braam, et al.
Annals of Surgical Oncology|July 8, 2015
Treatment-Related Mortality After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis is Underestimated by Conventional ParametersGeert A Simkens, Thijs R van Oudheusden, Hidde J Braam, et al.
British Journal of Clinical Pharmacology|December 15, 2010
Comparative evaluation of atracurium dosed on ideal body weight vs. total body weight in morbidly obese patientsSimone van Kralingen, Ewoudt M W van de Garde, Catherijne A J Knibbe, et al.
Annals of Surgical Oncology|March 28, 2014
Cytoreduction and hyperthermic intraperitoneal chemotherapy: a feasible and effective option for colorectal cancer patients after emergency surgery in the presence of peritoneal carcinomatosisThijs R van Oudheusden, Hidde J Braam, Simon W Nienhuijs, et al.
Surgical Endoscopy|February 14, 2008
Timing of cholecystectomy after endoscopic sphincterotomy for common bile duct stonesAnandi H W Schiphorst, Marc G H Besselink, Djamila Boerma, et al.
Pageof 11